Capping more than two years of stock-gyrating drama, Pfizer said it would stop development of danuglipron, its experimental ...

From STAT’s Matthew Herper: Pfizer said this morning that it would stop development of danuglipron, its experimental oral GLP ...

As the months ticked by in his job search, Albert started to wonder if there was something wrong with him. He got advice on ...

Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron, its ...

“We demonstrated that gut metabolites impact the brain, and the brain, in turn, affects behavior,” study author Lisa ...

The recent wave of layoffs and financial troubles at CRISPR-focused startups should not tarnish the promise of CRISPR.

The Office on Smoking and Health at the CDC is no more, putting state quitlines and national data on youth tobacco use at ...

The U.S. capacity to battle hepatitis B and C has been leveled a devastating blow with the recent closure of the CDC’s ...

A program to upgrade technology used by community health centers across the country is in limbo after HHS layoffs.

There are many good reasons why the U.S. should pay more for earlier access to new medications than its trading partners.

Donald Trump’s doctor says the oldest man to be elected president is “fully fit” to serve as commander in chief as the White ...

Verve Therapeutics said Monday that initial data show that its investigational gene-editing therapy lowered cholesterol without inducing serious side effects.